Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)

Clinical trial NCT01360866 · COMPLETED

Trial details

NCT number: NCT01360866
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder Depression Depressive Disorder, Major Mood Disorders Mental Disorders

Start date: 2011-10-01
Primary completion: 2017-04-18
Enrollment: 2944

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.